“Bogotá Your Home”: A Showcase of Bogotá’s New Image at COP16
BOGOTÁ, COLOMBIA / ACCESSWIRE / October 29, 2024 / "Bogotá tu casa" - "Bogotá Your Home", a campaign led by the District Institute of Tourism in collaboration with the Bogotá Chamber of Commerce and Invest in Bogotá, was showcased at COP16 to hundreds of visitors. The campaign highlighted the capital's key attributes and opportunities for tourists, entrepreneurs, and investors.
"As Invest in Bogotá, we supported this activation to show the world why Bogotá is a city full of opportunities for businesspeople, investors, and global-scale events. We look forward to guiding international decision-makers in exploring the city's investment opportunities as a platform for business expansion and growth", said Isabella Muñoz.
"Bogotá Your Home," the new campaign by the Bogotá District Institute of Tourism, the Bogotá Chamber of Commerce, and Invest in Bogotá, was promoted at COP16.
The event took place at the House of Bogotá and the Bogotá Chamber of Commerce at Bulevar del Río in Cali, the host city for the world's largest biodiversity summit. Attendees enjoyed an urban music show, a large-scale graffiti installation inspired by Bogotá's landscapes and ecosystems, and other activities.
"We are here proudly representing Bogotá, showcasing a city of opportunities that welcomes both locals and visitors. We strive to make Bogotá even greater because it deserves more", stated Ovidio Claros Polanco, Executive President of the Bogotá Chamber of Commerce.
The event also featured a digital photography exhibition titled "Bogotá, a Biodiverse Destination", which presented 16 of the capital's key green and conservation sites, such as wetlands, trails, viewpoints, and the stunning Sumapaz paramo.
The exhibition aimed to encourage visitors to discover these natural treasures, serving as both a visual portfolio and a tourist guide to explore Bogotá's biodiversity and its balance between urban and natural environments.
The campaign "Bogotá Your Home" seeks to captivate and inspire both locals and visitors, building trust and emotional connections. It is the result of a well-coordinated effort between the Mayor's Office of Bogotá, the Bogotá Chamber of Commerce, and Invest in Bogotá, institutions committed to the city's development and competitiveness. [Watch the official campaign video here.]
"Bogotá Your Home at COP16 exemplifies how coordinated tourism efforts between the Chamber of Commerce and Invest in Bogotá can strengthen the city's competitiveness and development", emphasized Andrés Santamaría, director of the District Institute of Tourism (IDT).
One of the most significant milestones of this campaign will take place on November 4th in New York City, when the campaign will light up the screens of Times Square to evoke emotions, build trust, and spark the interest of potential tourists, entrepreneurs, and investors, especially from the North American market.
"Path to Biodiversity Compliance from a Local Perspective"
During the weekend, the city's investment promotion agency also participated in several activities, including the panel discussion "Path to Biodiversity Compliance from a Local Perspective." This panel provided a space for exchanging experiences with local and regional stakeholders on developing tools and implementing actions to meet national and international biodiversity conservation goals.
Invest in Bogotá participated in the panel "Path to Biodiversity Compliance from a Local Perspective" at COP16.
Bogotá has already begun implementing an integrated strategy across land, air, and water to reduce pollution. This strategy includes restoring the eastern hills, participatory and efficient management of the city's main ecological structure, improving environmental quality-particularly in the city's southwest-and comprehensive watershed management, among other initiatives.
However, Mayor Carlos Fernando Galán called for greater inclusion of local administrations in these discussions: "It is essential that subnational governments have a voice that is heard. We possess the tools and the highest capacity to act in our territories. However, since we are not part of the negotiation stage, our voices often go unheard", he acknowledged.
Later, Invest in Bogotá participated in the CAF's (Andean Development Corporation) joint commitment to sustainable cities and biodiversity, where cities like Bogotá and Santa Marta prioritized nature conservation. The event also included the First Meeting of the Mayors' Forum on Urban Nature and Biodiversity, a space where cities reaffirmed their commitment to urban nature and biodiversity and called for increased funding for these efforts.
Signing of the Capital Cities Commitment -#BiodiverCities- to further integrate biodiversity into planning and sustainable development.
COP16 aims to establish agendas, commitments, and frameworks for conserving biological diversity, promoting sustainable use, and ensuring fair and equitable sharing of the benefits derived from genetic resources. The summit will conclude its agenda in Cali on November 1st.
Contact information
Phone number: (+57) 317 780 6158
Email: info@investinbogota.org
SOURCE: Invest in Bogota
View the original press release on accesswire.com
Invest in Bogota
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Polaris Renewable Energy Declares Quarterly Dividend31.10.2024 07:50:00 CET | Press release
TORONTO, ON / ACCESSWIRE / October 31, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding. This dividend will be paid on November 22nd, 2024 to shareholders of record at the close of business on November 11th, 2024. The dividend is an "eligible dividend" as designated for Canadian federal, provincial, and territorial income tax purposes. The board of directors of Polaris Renewable Energy remains committed to paying a quarterly dividend and will evaluate further dividend increases, as appropriate, going forward. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the acquisition, development, and operation of renewable energy projects in Latin America. We are a high-performing and financially sound contributor in the energy transition. The Company's operations
Polaris Renewable Energy Announces Q3 2024 Results31.10.2024 07:50:00 CET | Press release
TORONTO, ON / ACCESSWIRE / October 31, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the three and six months ended September 30, 2024. This earnings release should be read in conjunction with the Company's condensed consolidated interim financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise. HIGHLIGHTS Consolidated energy production of 168,639 MWh in the third quarter compared to 178,877 MWh in the third quarter of last year. The Company generated $17.7 million in revenue from energy sales for the quarter ended September 30, 2024, compared to $18.8 million in the same period in 2023. Lower revenue resulted from, principally, lower production in the Company's geothermal facilit
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio29.10.2024 08:00:00 CET | Press release
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. The company was founded as a spin-out of the University of Edinburgh, Scotland, together with lead investor Epidarex Capital, a leading early-stage transatlantic venture fund, along with IP Group, and Scottish Enterprise. Effective immediately, Kynos Therapeutics will be integrated into the Falk Group. Dr. Falk Pharma Dr. Falk Pharma Logo Kynos Therapeutics' lead investigational asset is KNS366, a highly potent and selective first-in-class inhibitor of the enzyme kynurenine 3-monooxygenase (KMO). In a Phase I clinical trial, KNS366 was shown to be safe and well-tolerated at multiple doses. The compound also led to a dose-dependent inhibition of the enzyme KMO and modulation of its downs
Polaris Renewable Energy Announces Acquisition Transaction in Puerto Rico29.10.2024 07:50:00 CET | Press release
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company"), is pleased to announce that it has entered into an Equity Capital Contribution Agreement ("ECCA") with respect to Punta Lima Wind Farm LLC (a wholly owned subsidiary of Santander Bank N.A. -"Santander"-). The project is an operating onshore wind farm called Punta Lima Wind Farm ("PLWF" or the "Project") with a nameplate capacity of 26.0 MW's located in the Municipality of Naguabo, Puerto Rico. The Project was re-constructed and recommissioned by Santander and has a 20-year power purchase agreement ("PPA") in place with Puerto Rico Electric Power Authority (PREPA) terminating in March 2044. The transaction is being completed using a tax-equity structure which will result in Polaris becoming the manager and operator of the Project with a controlling equity interest and Santander retaining a tax equity interest in the Project. the transaction is subject to customary closing
BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases29.10.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that it has initiated the nationalization process for the filing of a family of patents for the sublingual delivery of anticancer drugs for the treatment of autoimmune neurodegenerative diseases. The patents are 100% owned by BioNxt. Subject to the international Patent Cooperation Treaty ("PCT"), the European Patent Office ("EPO") issued a positive International Preliminary Report on Patentability ("IPRP"), announced by the Company on September 9, 2024. The EPO accepted the Company's claim that the patent family was new, useful, and non-obvious, satisfying the requirements for patentability. Based on the report's findings, BioNxt is advancing its patent protection process to national level filings in the following international jurisdictions: Independent filing nations: Australia (AU), Canada (CA), New Zealand (NZ), USA (US), Japan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom